Do We Overestimate How Well Drugs Work?

TL;DR

Research shows that medication effectiveness is often overstated—not because drugs don’t work, but because negative or inconclusive trials are far less likely to be published. Antidepressants, sleep medications, and other drug classes frequently appear more effective in journals than they do in FDA data. This “selective publication” can shape prescribing decisions and public perception. Understanding these gaps encourages a more balanced approach that includes nutrition, lifestyle, and other terrain-based factors that support sleep, mood, and stress resilience.

Educational only; not medical advice.

Most people assume that prescription medications are thoroughly tested, highly effective, and accurately represented in the scientific literature. But research over the past two decades shows that the effectiveness of many medications is often overstated, not because the drugs “don’t work,” but because the evidence we see as the public—and even as clinicians—is incomplete.

The Influence of the Drug Industry

Richard Smith, former editor of the British Medical Journal (BMJ), publicly criticized his former publication, saying that they were too dependent on advertising revenue to be considered impartial [1]. As a result, we have multibillion-dollar corporations controlling our observations and our conversations about health—it is not very scientific.

The Problem of Selective Publication

One of the clearest examples comes from antidepressant trials. In 2008, Erick Turner, MD, and colleagues compared FDA-submitted trials with the published literature in major journals.
They found:

94% of published studies showed a positive benefit
But FDA data showed only 51% were actually positive

Studies with disappointing results were far less likely to be published, creating the illusion that medications perform better than they do in real life [2].

Publication bias isn’t unique to antidepressants—it has been identified across multiple drug classes, including pain medications, antipsychotics, and certain sleep drugs.

Sleep Medications: Helpful, but More Modest Than Expected

Prescription use for mental-health–related conditions remains extremely common in the U.S. For example, recent CDC data show that more than 13% of adults report taking an antidepressant, and use has increased steadily over the past two decades, including significant growth among adolescents. (Source: CDC National Center for Health Statistics, 2015–2018 data.) At the same time, research has shown that published drug trials often present a much more favorable picture than the underlying evidence. A landmark analysis in The New England Journal of Medicine compared FDA-submitted antidepressant trials with the studies that actually appeared in medical journals. While 94% of published trials reported positive results, the FDA’s own review found that only 51% were truly positive. The rest were unpublished or published in a way that conveyed an inflated impression of benefit. The study’s lead author, Erick Turner, MD, warned that this kind of selective publication can “lead doctors and patients to believe drugs are more effective than they really are,” influencing prescribing decisions [3].

Why These Gaps Matter

When negative or neutral studies go unpublished, doctors and patients get an overly optimistic picture of:

how well a drug works
who benefits most
how the drug compares with non-drug options
potential risks
long-term outcomes

This can influence prescribing patterns and expectations.

Better Sleep and Mood Often Start with the “Terrain”

Medications absolutely have their place. But because drug effectiveness is sometimes overstated—often unintentionally—it’s important to remember that sleep, mood, and stress resilience also depend heavily on:

nutrient status (magnesium, B vitamins, omega-3s)
stress levels
circadian rhythms
caffeine and alcohol intake
inflammation
digestive health
physical activity

These “terrain” factors influence neurotransmitters, hormones, and sleep architecture in ways that medication alone cannot fully address.

FAQ

Why would medical journals publish selectively positive studies?

Selective publication often happens because companies tend to submit positive trials for publication and leave negative trials unpublished. Journals also prefer studies showing strong results. Also, the pharmaceutical industry has a powerful influence on medical journals. Journals are financially dependent on it. This combination creates a skewed picture of effectiveness in the scientific literature.

Does selective publication mean medications don’t work?

No. Some medications do provide benefit. The problem is that the size of the benefit may be exaggerated in published studies, leading to unrealistic expectations.

Is this only true for antidepressants?

No. Selective publication has been identified across multiple drug categories, including analgesics, antipsychotics, and certain sleep medications. It is a systemic issue in medical research.

Why does the FDA have different results?

The FDA sees all trials—positive, negative, or neutral—because companies must submit full data when seeking approval. Journals only see what gets submitted to them.

What does this mean for patients?

It means patients and doctors may assume medications work better than they actually do, or may overlook non-drug factors (nutrients, lifestyle, stress, inflammation, sleep hygiene) that play an important role in real-world outcomes.

Should people stop taking their medications?

No. This article is educational only—not medical advice. Medications should never be stopped without working closely with doctors trained in natural healthcare.